HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

Social Networks
Drug Updates
Chronic Kidney Disease (CKD) is characterised by a gradual and permanent loss of kidney function that worsens as it progresses from stages 1 to 5. One of the most common complications of CKD is anaemia. Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age. Parkinson's disease (PD) is a degenerative disorder of the central nervous system characterized by the clinically asymmetric onset of resting tremor, bradykinesia, rigidity and postural instability. Prostate Cancer
EPG Online Guidelines by Subject
Subject | Publisher | Year Order: A to Z - Z to A

Acne

Acute Coronary Syndrome

Acute Coronary Syndromes (ACS)

  • ESC Guidelines on Myocardial Revascularization

    European Society of Cardiology (Nov 2011)

    Formulation of the best possible revascularization approach, taking into consideration the social and cultural context also, will often require interaction between cardiologists and cardiac surgeons, referring physicians or other specialists as desirable. Patients need help in taking informed decisions about their treatment, and the most valuable advice will likely be provided to them by the Heart Team.

Acute Pulmonary Embolism

ADHD

  • ADHD Clinical Practice Guidelines

    American Academy of Pediatrics (Nov 2011)

    This clinical practice guideline provides recommendations for the assessment and diagnosis of school-aged children with attention-deficit/hyperactivity disorder (ADHD). This guideline, the first of 2 sets of guidelines to provide recommendations on this condition, is intended for use by primary care clinicians working in primary care settings. The second set of guidelines will address the issue of treatment of children with ADHD.

  • Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults

    NICE (Sep 2008)

    This guideline makes recommendations for the diagnosis and management of attention deficit hyperactivity disorder (ADHD) in children, young people and adults. The guideline does not cover the management of ADHD in children younger than 3 years. The term ‘children’ refers to those aged 11 years and younger; ‘young people’ refers to those between 12 and 18 years. However, these categories are flexible and clinicians should use their judgement about a child or young person’s developmental, as opposed to their chronological, age.

  • Management of attention deficit and hyperkinetic disorders in children and young people

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    The overall aim of this national guideline update is to provide a framework for evidence based assessment and management of ADHD/HKD, from which multidisciplinary and multiagency approaches can be developed locally.

Allergic Reaction

Alzheimer's disease

  • Dementia

    NICE (May 2007)

    This guideline has been developed to advise on supporting people with dementia and their carers in health and social care. The guideline recommendations have been developed by a multidisciplinary team of health and social care professionals, a person with dementia, carers and guideline methodologists after careful consideration of the best available evidence. It is intended that the guideline will be useful to practitioners and service commissioners in providing and planning high-quality care for those with dementia while also emphasising the importance of the experience of care for people with dementia and carers.

  • EFNS guidelines for the diagnosis and management of Alzheimer's disease

    European Federation of Neurological Societies (Nov 2011)

    The aim of this revised international guideline was to present a peer-reviewed evidence-based statement for the guidance of practice for clinical neurologists, geriatricians, psychiatrists, and other specialist physicians responsible for the care of patients with AD. Mild cognitive impairment and non- Alzheimer dementias are not included in this guideline.

Anaemia

Angina

  • Unstable angina and NSTEMI

    NICE (Mar 2012)

    The term ‘acute coronary syndromes’ encompasses a range of conditions from unstable angina to ST-segment-elevation myocardial infarction (STEMI), arising from thrombus formation on an atheromatous plaque. This guideline addresses the early management of unstable angina and non-ST-segmentelevation myocardial infarction (NSTEMI) once a firm diagnosis has been made and before discharge from hospital. If untreated, the prognosis is poor and mortality high, particularly in people who have had myocardial damage. Appropriate triage, risk assessment and timely use of acute pharmacological or invasive interventions are critical for the prevention of future adverse cardiovascular events (myocardial infarction, stroke, repeat revascularisation or death).

Antenatal Care

  • Antenatal care

    NICE (Mar 2008)

    The advice in the NICE guideline covers : the routine care that all healthy women can expect to receive during their pregnancy.

Antisocial Personality Disorder

Anxiety

  • Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults

    NICE (Nov 2011)

    This clinical guideline (published January 2011) updates and replaces NICE clinical guideline 22 (published December 2004; amended April 2007). It offers evidence-based advice on the care and treatment of adults with generalised anxiety disorder or panic disorder (with or without agoraphobia. New and updated recommendations on the management of generalised anxiety disorder were included in 2011.

Arthritis

  • Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor

    NICE (Nov 2011)

    The appraisal of adalimumab and the review of the appraisals of etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis have resulted in changes in the guidance. Rituximab in combination with methotrexate is still recommended as an option for the treatment of adults with severe active rheumatoid arthritis who have had an inadequate response to, or have an intolerance of, other DMARDs, including at least one TNF inhibitor. Additional treatment options are now recommended for these adults if rituximab therapy is contraindicated or withdrawn because of an adverse event, specifically: If rituximab is contraindicated or withdrawn, adalimumab, etanercept, infliximab and abatacept, each in combination with methotrexate, are now recommended as treatment options. If rituximab therapy cannot be given because methotrexate is contraindicated or withdrawn because of an adverse event, adalimumab and etanercept, each as monotherapy, are now recommended as treatment options.

  • BSR guidelines on standards of care for persons with rheumatoid arthritis

    Oxford Journals (Feb 2005)

    This document is intended to help and support the rheumatology team by providing a statement of the minimum standard of care requirements for persons with rheumatoid arthritis. It can also act as the formal record of standards of care as part of the clinical governance process of any rheumatology unit.

  • Osteoarthritis

    NICE (Feb 2008)

    The advice in the NICE guideline covers the treatment, advice and support that people who have osteoarthritis should be offered by their healthcare professional and when being referred to specialist care.

Asthma

  • British Guideline on the Management of Asthma

    British Thoracic Society (Mar 2012)

    This guideline provides recommendations based on current evidence for best practice in the management of asthma. It makes recommendations on management of adults, including pregnant women, adolescents, and children with asthma

  • British Guideline on the Management of Asthma (revised january 2012)

    British Thoracic Society (Mar 2012)

    This guideline provides recommendations based on current evidence for best practice in the management of asthma. It makes recommendations on management of adults, including pregnant women, adolescents, and children with asthma

  • Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma

    National Heart Lung and Blood Institute (Aug 2007)

    The EPR 3 Guidelines on Asthma was developed by an expert panel commissioned by the National Asthma Education and Prevention Program (NAEPP) Coordinating Committee (CC), coordinated by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Using the 1997 EPR 2 guidelines and the 2004 update of EPR 2 as the framework, the expert panel organized the literature review and final guidelines report around four essential components of asthma care, namely: assessment and monitoring, patient education, control of factors contributing to asthma severity, and pharmacologic treatment. Subtopics were developed for each of these four broad categories.

Atopic Eczema

  • Atopic eczema in children

    NICE (Dec 2007)

    Clinical guidelines have been defined as ‘systematically developed statements which assist clinicians and patients in making decisions about appropriate treatment for specific conditions’. This clinical guideline concerns the management of atopic eczema in children from birth up to the age of 12 years. It has been developed with the aim of providing guidance on: • diagnosis and assessment of the impact of the condition • management during and between flares • information and education to children and their families/caregivers about the condition.

  • Management of atopic eczema in primary care

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    This guideline focuses on providing recommendations for the management of atopic eczema in children and adults in primary care, based on current evidence for best practice. It includes advice on the various topical treatments for atopic eczema (including emollients (moisturisers), topical corticosteroids, topical calcineurin inhibitors and dressings), anti-infective treatments (such as antibiotics and antiseptics), antihistamines, complementary therapies and the roles of diet and environmental factors. It excludes treatments that are usually carried out in secondary care, such as phototherapy and systemic immunosuppressant drugs.

Atrial Fibrillation

  • Atrial fibrillation

    NICE (Jun 2008)

    The NICE clinical guideline on atrial fibrillation covers:

  • ESC Management of Atrial Fibrillation

    European Society of Cardiology (Nov 2011)

    Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2% of the general population. Over 6 million Europeans suffer from this arrhythmia, and its prevalence is estimated to at least double in the next 50 years as the population ages. It is now 4 years since the last AF guideline was published, and a new version is now needed.

Autism Spectrum Disorders (ASD)

Autoimmune Hepatitis

Autoimmune Neuromuscular Transmission Disorders

Back Pain

Bacterial Infection

Benign Prostatic Hyperplasia

Bipolar Disorder

  • Bipolar disorder : The management of bipolar disorder in adults, children and adolescents, in primary and secondary care

    NICE (Jul 2006)

    The advice in the NICE guideline covers the care of: - adults who, as a result of critical illness, have stayed in critical care and need rehabilitation. It does not specifically look at the care of: - adults who are having treatment for symptoms and pain in the final stages of a terminal illness - adults whose rehabilitation needs are already routinely assessed and delivered as part of their care, for example, patients who have brief stays in critical care units for immediate postoperative care after major elective surgery, and patients with conditions for which published guidelines already exist – such as head injury, heart attack and stroke.

Bladder Cancer

  • Bladder Cancer Muscle-invasive and Metastatic

    European Association of Urology (Nov 2011)

    The European Association of Urology (EAU) Guideline Panel for Muscle-invasive and Metastic Bladder Cancer (MIBC) has prepared these guidelines to help urologists assess the evidence-based management of MIBC and to incorporate guideline recommendations into their clinical practice. The EAU Guidelines Panel consists of an international multidisciplinary group of experts in this field. It is evident that optimal treatment strategies for MIBC require the involvement of a specialist multidisciplinary team and a model of integrated care to avoid fragmentation of patient care.

  • Guidelines on TaT1 (Non-muscle invasive) Bladder Cancer

    European Association of Urology (Nov 2011)

    the guidelines group on non-muscle-invasive bladder cancer decided to integrate the guidelines of TaT1 tumours and CIS in one issue. This overview represents the updated EAU guidelines for non-muscle-invasive bladder cancer (CIS, Ta, T1).

Blood Pressure

  • Blood Pressure Monitoring

    UCL (Nov 2011)

    This guideline offers a definition of what is a blood pressure as well as describing its various phases. It also highlights the difficulties as well as methods and types of equipment used in measuring blood pressure in children/young people. The appendix demonstrates tables of blood pressure measurements for boys and girls aged between 1 and 17 years in relation to 90th and 95th percentiles.

Borderline Personality Disorder

Brain Cancer

  • Brain metastases

    European Federation of Neurological Societies (Nov 2011)

    The primary objective has been to establish evidence - based guidelines in regard to the management of patients with brain metastases. The secondary objective has been to identify areas where there are still controversies and clinical trials are needed.

Breast Cancer

Breast Milk

  • Donor breast milk banks

    NICE (Feb 2012)

    The advice in the NICE guideline covers: How milk banks should recruit, screen and support women who donate breast milk How milk banks should handle and process the breast milk they receive from donors.

Bronchiolitis

  • Bronchiolitis in children

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    There is widespread variation in the management of infants with bronchiolitis both in hospital and, anecdotally, in the community.The guideline aims to reduce the use of unnecessary therapies and investigations, particularly in the acute illness, and to guide referral patterns from primary to secondary and for some, tertiary care.

Bronchoscopy

Caesarean Section

  • Caesarean section

    NICE (Apr 2004)

    The NICE caesarean section clinical guideline covers: - the information women can expect to receive from their doctor or midwife about caesarean section - the most common reasons why they might need to have a caesarean section - the benefits and risks of having a baby by a caesarean section compared with a vaginal birth - what can be done to reduce the chances that women will need a caesarean section - routine tests and treatments you should be offered women who have a caesarean section - the care they can expect to receive before, during and after a caesarean section

Cancer

  • Clinical practice guidelines for the psychosocial care of adults with cancer

    National Health and Medical Research Council (Mar 2012)

    These evidence-based guidelines have been designed for use by all health professionals who come in contact with people during the course of cancer diagnosis and treatment. The document is multidisciplinary in its focus and the recommendations applicable to diverse treatment settings.

  • Control of pain in adults with cancer

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    This guideline provides recommendations based on current evidence for best practice in the management of pain in adult patients who have cancer. The guideline includes advice mainly concerning pain secondary to the cancer, but many of the principles outlined are applicable to coexisting painful conditions and pain secondary to treatment of the cancer. It excludes the treatment of pain in children under the age of 12.

  • Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

    JMG: Journal of Medical Genetics (Feb 2007)

    In April 2006, a workshop was organised by a group of European experts in hereditary gastrointestinal cancer (the Mallorca-group), aiming to establish guidelines for the clinical management of Lynch syndrome. 21 experts from nine European countries participated in this workshop. Prior to the meeting, various participants prepared the key management issues of debate according to the latest publications. A systematic literature search using Pubmed and the Cochrane Database of Systematic Reviews reference lists of retrieved articles and manual searches of relevant articles was performed. During the workshop, all recommendations were discussed in detail. Because most of the studies that form the basis for the recommendations were descriptive and/or retrospective in nature, many of them were based on expert opinion. The guidelines described in this manuscript may be helpful for the appropriate management of families with Lynch syndrome. Prospective controlled studies should be undertaken to improve further the care of these families.

  • Referral for suspected cancer

    NICE (Jun 2005)

    This guideline is an update of the guideline entitled ‘Referral guidelines for suspected cancer’ published by the Department of Health in 2000. The new guideline takes account of new research evidence and the findings of audits undertaken since the publication of the previous guideline. The recommendations made here supersede those in the earlier guideline.

Cardiovascular Disease

Cerebral Vasculitis

Cervical Cancer

  • Management of cervical cancer

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    The optimal management of cervical cancer involves a multidisciplinary team. The challenge for the team is to individualise treatment. As cervical cancer commonly occurs between the ages of 30 and 45, this includes offering women with early disease the option of having fertility conserving surgery, where appropriate. For those with intermediate or advanced disease the aim is to minimise treatment side effects without compromising the outcome.

Chest Pain

Chronic Fatigue Syndrome

  • Chronic fatigue syndrome / Myalgic encephalomyelitis

    NICE (Aug 2007)

    The guideline covers care provided by healthcare professionals who have direct contact with and make decisions about the care of people with chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy) (CFS/ME). It covers care provided in primary and secondary care, and in specialist centres/teams.

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Chronic Kidney Disease

Chronic Pelvis Pain

  • Guidelines on Chronic Pelvis Pain

    European Association of Urology (Mar 2008)

    The European Association of Urology (EAU) Guidelines Group for Chronic Pelvic Pain have prepared this guidelines document to help medical professionals assess the evidence-based management of chronic pelvic pain. The multidisciplinary panel of experts includes urologists, a neuro-urologist, anaesthesiologists, a gynaecologist and a psychologist.

Chronic Venous Leg Ulcers

  • Management of chronic venous leg ulcers

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    This guideline provides evidence based recommendations on the management of venous leg ulcers and examines assessment, treatment and the prevention of recurrence. Evidence on provision of care is also presented. The guideline does not cover detailed management of patients with chronic leg ulcer in the specialist fields of diabetes, vascular surgery or rheumatoid disease, although indications for referral are considered.

Coeliac Disease

  • Recognition and assessment of coeliac disease

    NICE (May 2009)

    This guideline offers best practice advice on the recognition and assessment of coeliac disease and the care of children and adults who are undergoing the diagnostic process for coeliac disease.

Colorectal Cancer

Common Bile Duct Stones

Congenital Heart Disease

  • ESC Guidelines for the management of grown-up congenital heart disease

    European Society of Cardiology (Nov 2011)

    The aim of practice guidelines is to be evidence based, but, in a relatively young specialty dealing with a variety of diseases and frequently small patient numbers, there is a lack of robust data. It is therefore difficult to use categories of strength of endorsement as have been used in other guidelines documents. The vast majority of recommendations must unfortunately remain based on expert consensus rather than on solid data (level of evidence C).

COPD

  • Chronic obstructive pulmonary disease

    NICE (Nov 2011)

    This guidance is for the care and treatment of people with chronic obstructive pulmonary disease (which is usually shortened to COPD) in the NHS in England and Wales. It explains guidance (advice) from NICE (the National Institute for Health and Clinical Excellence). It is written for people with COPD but it may also be useful for their families or carers or for anyone with an interest in the condition.

Critical Illness

  • Rehabilitation after Critical Illness

    NICE (Mar 2009)

    The advice in the NICE guideline covers the care of adults who, as a result of critical illness, have stayed in critical care and need rehabilitation.

Cytoreduction Surgery

  • Cytoreduction surgery followed by hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis

    NICE (Dec 2003)

    Peritoneal metastases commonly result from the regional spread of gastrointestinal, gynaecological and other malignancies. Peritoneal carcinomatosis is an advanced form of cancer associated with short survival and poor quality of life, which may lead to bowel obstruction, ascites and pain. This procedure was developed by Paul Sugarbaker at the Washington Cancer Institute. A laparotomy is performed under general anaesthesia and all gross tumour is removed along with the involved organs, peritoneum and tissue.

Deep Vein Thrombosis

Dental

  • Dental recall

    NICE (Oct 2004)

    The purpose of this guideline is to help clinicians assign recall intervals between oral health reviews that are appropriate to the needs of individual patients. The recommendations apply to patients of all ages (both dentate and edentulous) receiving primary care from NHS dental staff in England and Wales. The guideline takes into account the potential of the patient and the dental team to improve or maintain the patient’s quality of life and to reduce morbidity associated with oral and dental disease.

Dependency

  • Alcohol - related seizures

    European Federation of Neurological Societies (Nov 2011)

    These guidelines summarize the current evidence for the diagnosis and management of alcohol - related seizures.

  • Alcohol-use disorders: Diagnosis, assessment and management of harmful drinking and alcohol dependence

    NICE (Mar 2012)

    This guideline makes recommendations on the diagnosis, assessment and management of harmful drinking and alcohol dependence in adults and in young people aged 10–17 years.

  • Alcohol-use disorders: physical complications

    NICE (Jun 2010)

    The care of adults and young people (aged 10 years and older) who have any health problems that are completely or partly caused by alcohol use

  • Drug misuse - methadone and buprenorphine: full guidance

    NICE (Nov 2011)

    Methadone and buprenorphine (given as a tablet or a liquid) are recommended as treatment options for people who are opioid dependent. A decision about which is the better treatment should be made on an individual basis, in consultation with the person, taking into account the possible benefits and risks of each treatment for that particular person. If both drugs are likely to have the same benefits and risks, methadone should be given as the first choice. Different people will need different doses of methadone or buprenorphine. People should take methadone or buprenorphine daily in the presence of their doctor, nurse or community pharmacist for at least the first 3 months of treatment and until they are able to continue their treatment correctly without supervision. Treatment with methadone or buprenorphine should be given as part of a support programme to help the person manage their opioid dependence.

Depression

  • Clinical practice guidelines: Depression in adolescents and young adults

    National Health and Medical Research Council (Mar 2012)

    The Guidelines summarise published evidence based on high quality research and make recommendations on key areas of care. Across the continuum of care, there are areas where it is not possible to make evidencebased recommendations, particularly for young adults. In areas for which there is insufficient research evidence for recommendations, the Guidelines include good practice points that are based on lower quality evidence, international guideline documents (e.g. the United Kingdom [UK] National Institute for Health and Clinical Excellence and the American Academy of Child and Adolescent Psychiatrists) and/or best practice clinical judgement

  • Depression

    NICE (Dec 2004)

    This guideline was first published in December 2004 (NICE, 2004a; NCCMH, 2004) (referred to as the ‘previous guideline’). The present guideline (referred to as the ‘update’) updates many areas of the previous guideline. There are also new chapters on the experience of depression for people with depression and their carers (Chapter 4), and on the treatment and management of subthreshold depressive symptoms (including dysthymia symptoms) (Chapter 13), which were not part of the scope of the previous guideline. Recommendations categorised as ‘good practice points’ in the previous guideline were reviewed for their current relevance (including issues around consent and advance directives). Further details of what has been updated and what is left unchanged can be found at the beginning of each evidence chapter. The scope for the update also included updating two National Institute for Health and Clinical Excellence (NICE) technology appraisals (TAs) on the use of electroconvulsive therapy (ECT) (TA59) and on computerised cognitive behaviour therapy.

  • Depression in children and young people

    NICE (Sep 2005)

    The NICE clinical guideline on depression in children and young people covers: - the care children and young people with depression can expect to get from their doctor, nurse or counsellor - the information they can expect to be given - what they can expect from treatment - the kinds of services that can help young people and children with depression, including your family doctor (general practitioner or GP), health staff at your school, and specialists in clinics or hospitals

  • Depression with a chronic physical health problem

    NICE (Oct 2009)

    This guideline makes recommendations on the identification, treatment and management of depression in adults aged 18 years and older who also have a chronic physical health problem (such as cancer, heart disease, diabetes, or a musculoskeletal, respiratory or neurological disorder).

  • Non-pharmaceutical management of depression in adults

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    The focus of the guideline is to examine the evidence for depression treatments which may be used as alternatives to prescribed pharmacological therapies. Interventions were prioritised for inclusion by the guideline development group if they were known to be delivered, or be under consideration for delivery, by NHS services in Scotland or if, based on the experience of group members, they were interventions which patients asked about or sought outside of the health service.

Dermatitis

  • Guidelines for care of contact dermatitis

    British Journal of Dermatology (Sep 2001)

    These guidelines have been prepared for dermatologists on behalf of the British Association of Dermatologists and reflect the best data available at the time the report was prepared. Caution should be exercised in interpreting the data; the results of future studies may require alteration of the conclusions or recommendations in this report. It may be necessary or even desirable to depart from the guidelines in the interests of specific patients and special circumstances. Just as adherence to guidelines may not constitute defence against a claim of negligence, so deviation from them should not necessarily be deemed negligent.

Diabetes

  • Blood glucose monitoring

    Great Ormond Street Hospital for Children (Oct 2008)

    When performing blood glucose monitoring, staff should be trained in both the theoretical & practical aspects, including the use of the glucose measuring device & instruction on calibration of quality control.

  • Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus

    NICE (Jul 2008)

    The review and re-appraisal of the use of continuous subcutaneous insulin infusion for the treatment of diabetes mellitus has resulted in a change in the guidance. Specifically there has been a change to the recommendation on the use of continuous subcutaneous insulin infusion in children younger than 12 years with type 1 diabetes mellitus.

  • Diabetes in pregnancy

    NICE (Mar 2008)

    This clinical guideline contains recommendations for the management of diabetes and its complications in women who wish to conceive and those who are already pregnant. The guideline builds on existing clinical guidelines for routine care during the antenatal, intrapartum and postnatal periods. It focuses on areas where additional or different care should be offered to women with diabetes and their newborn babies.

  • Diabetic foot problems: Inpatient management of diabetic foot problems

    NICE (Mar 2012)

    This short clinical guideline aims to provide guidance on the key components of inpatient care of people with diabetic foot problems from hospital admission onwards.

  • Management of diabetes

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    This guideline provides recommendations based on current evidence for best practice in the management of diabetes. For people with type 1 and type 2 diabetes recommendations for lifestyle interventions are included, as are recommendations for the management of cardiovascular, kidney and foot diseases

  • Type 1 diabetes

    NICE (Sep 2004)

    The NICE clinical guideline on type 1 diabetes covers the NHS care that should be available to adults with type 1 diabetes. It includes recommendations on how the diagnosis should be made and the options that should be offered at different times.

  • Type 2 Diabetes - Diabetic Retinopathy: Early Management and Screening

    NICE (Mar 2002)

    The national clinical guideline for Type 2 diabetes is comprised of a series of six inter-related guidelines that deal with different aspects of Type 2 diabetes. Throughout this document the entire series of guidelines is referred to as ‘the national guideline’. The aim of the national guideline is to provide recommendations to assist health care professionals in their management of people with Type 2 diabetes and is aimed at all health care professionals providing care to people with diagnosed Type 2 diabetes in primary and secondary care, irrespective of location. Depending on the type, stage and severity of clinical problem, the guidelines may also be valuable to those who work in the tertiary sector of diabetes care.

  • Type 2 Diabetes - Management of Blood Glucose

    National Clinical Guideline (Sep 2009)

    The NICE clinical guideline on type 2 diabetes – blood glucose covers the management of blood glucose levels and looks at its role in limiting or preventing complications of the condition.

  • Type 2 Diabetes - Management of Blood Pressure and Blood Lipids

    NICE (Oct 2001)

    This guideline is one of a series on type 2 diabetes; others in the series cover: • screening for retinopathy and early management of the condition (guidance was issued by the National Institute for Clinical Excellence in February 2002) • the prevention and early management of renal disease (guidance was issued by the National Institute for Clinical Excellence in February 2002) • the management of blood glucose (guidance was issued by the National Institute for Clinical Excellence in September 2002) • foot care ( the original guideline, published by the Royal College of General Practitioners in April 2000, will be updated by the National Institute for Clinical Excellence in 2003/04).

  • Type 2 Diabetes - Newer Agents for Blood Glucose Control in Type 2 Diabetes

    NICE (May 2009)

    This guideline offers best practice advice on the care of people with type 2 diabetes. It does not address care in or before pregnancy, or care by specialist services for specific advanced organ damage (cardiac, renal, eye, vascular, stroke and other services).

  • Type 2 Diabetes - Renal Disease: Prevention and Early Management

    NICE (Mar 2003)

    The NICE clinical guideline on type 2 diabetes and renal disease covers the prevention and management of renal (kidney) disease.

  • Type 2 diabetes: The Management of Type 2 Diabetes (update)

    NICE (May 2009)

    This guideline is concerned only with Type 2 diabetes. The underlying disorder is usually that of a background of insulin insensitivity plus a failure of pancreatic insulin secretion to compensate for this.

Diarrhoea and Vomiting

  • Management of acute diarrhoea and vomiting due to gastoenteritis in children under 5

    NICE (Apr 2009)

    This guideline is intended to apply to children younger than 5 years in England and Wales who present to a healthcare professional for advice in any setting. Importantly, it differs from other guidelines in that it was developed using a set of important principles employed for all NICE clinical guidelines. At the outset there was a process of national consultation to determine the key areas of management that should be addressed and to define the exact ‘scope’ of the guideline. Recommendations were based on the best available evidence whenever possible.

Drug Misuse

  • Drug Misuse and Dependence: UK Guidelines on Clinical Management

    Department of Health (Sep 2007)

    This document updates and replaces Drug Misuse and Dependence – Guidelines on Clinical Management (UK health departments 1999) – hereafter referred to as the 1999 Clinical Guidelines. It has the same status across the UK as the 1999 Clinical Guidelines.

  • Drug misuse: opioid detoxification

    NICE (Jul 2007)

    This guideline has been developed to advise on opioid detoxification for drug misuse. The guideline recommendations have been developed by a multidisciplinary team of healthcare professionals, service users, a carer and guideline methodologists after careful consideration of the best available evidence. It is intended that the guideline will be useful to clinicians and service commissioners in providing and planning high-quality care for people who misuse drugs while also emphasising the importance of the experience of care for people who misuse drugs and their carers (see Appendix 1 for more details on the scope of the guideline).

  • Drug misuse: psychosocial interventions

    NICE (Jan 2007)

    This guideline makes recommendations for the use of psychosocial interventions in the treatment of people who misuse opioids, stimulants and cannabis in the healthcare and criminal justice systems. The patterns of use vary for these drugs, with cannabis the most likely to be used in the UK. Cocaine is the next most commonly used drug in the UK, followed by other stimulants such as amphetamine. Opioids, although presenting the most significant health problem, are used less commonly. A large proportion of people who misuse drugs are polydrug users and do not limit their use to one particular drug. This guideline will not deal with recreational drug use, although opportunistic brief interventions for people who misuse drugs but who are not in formal drug treatment are included. The guideline also does not specifically address drug misuse in pregnancy.

  • Guidance for the pharmacological management of substance misuse among young people

    National treatment agency (Nov 2011)

    A prerequisite of pharmacological management is a comprehensive assessment of the young person’s needs and risks to that young person, and the establishment of a care plan. Pharmacological management should be provided in conjunction with psychosocial interventions and support, including risk management tailored to the individual. Aftercare provision needs to be put in place, which includes psychosocial interventions to prevent relapse.

Dyspepsia

  • Dyspepsia

    NICE (Aug 2004)

    This national guideline provides evidence-based recommendations for the primary care management of dyspepsia symptoms and underlying causes in adults.

Ear Infection

  • Surgical management of OME

    NICE (Feb 2008)

    The guideline has been developed with the aim of providing guidance on the appropriate criteria for referral, assessment and optimum surgical management of children younger than 12 years with a suspected diagnosis of OME’ for use in the NHS in England, Wales and Northern Ireland.

Eating Disorders

  • Eating disorders

    NICE (Aug 2004)

    The NICE eating disorders clinical guideline covers physical and psychological treatments, treatment with medicines, and what kinds of services best help people with eating disorders.

Eczema

  • Atopic eczema in children

    NICE (Dec 2007)

    This clinical guideline concerns the management of atopic eczema in children from birth up to the age of 12 years.

Epidural Adhesions

Epilepsy

Falls

  • Falls

    NICE (Nov 2004)

    The NICE clinical guideline on falls covers older people who live in the community, either at home, in a retirement complex, or in a residential or nursing home. In this guideline, an older person is defined as someone who is aged 65 or older.

Fertility / Pregnancy

  • Caesarean section

    NICE (Mar 2012)

    This guideline offers best practice advice on the care of pregnant women who may require a CS.

  • Fertility assessment and treatment for people with fertility problems

    Royal College of Obstetricians and Gynaecologists, (Feb 2002)

    The aim of this guideline is to offer best practice advice on the care of people in the reproductive age group who perceive that they have problems in conceiving. Between 1998 and 2000, the Royal College of Obstetricians and Gynaecologists (RCOG) published three guidelines on the management of infertility that covered, respectively, initial investigation and management, management in secondary care and management in tertiary care. This guideline is based on those RCOG guidelines and takes into account a new review of the research evidence; it also covers the diagnostic, medical and surgical management of people throughout all stages of their care in primary-, secondary- and tertiary-care settings.

  • Induction of labour

    NICE (Jun 2004)

    The purpose of this guideline is to review all aspects of the methodology of induction of labour and the appropriateness of different approaches in the various clinical circumstances that may call for such an intervention.

  • Intrapartum care

    NICE (Sep 2007)

    The advice in the NICE guideline covers healthy women who are giving birth at 37-42 weeks (known as 'term').

  • Multiple pregnancy: The management of twin and triplet pregnancies in the antenatal period

    NICE (Mar 2012)

    This guideline offers best practice advice on the care of women with twin and triplet pregnancies

  • Postnatal care

    NICE (Jul 2006)

    The NICE clinical guideline on postnatal care covers the core care that every healthy woman and healthy baby should be offered during the first 6-8 weeks after the birth.

Follicular lymphoma

  • Rituximab for the treatment of follicular lymphoma

    NHS (Jun 2009)

    Rituximab within its licensed indication (that is, in combination with cyclophosphamide, vincristine and prednisolone) is recommended as an option for the treatment of symptomatic stage III and IV follicular lymphoma in previously untreated patients.

Gastric Polyps

  • The Management of Gastric Polyps

    British Society of Gastroenterology (Nov 2011)

    This guideline aims to characterise gastric polyps and provide a framework for management. However, recommendations for diagnosis and treatment of these polyps remain controversial, as there is no consensus. Specifically, these guidelines do not cover the management of early gastric cancer.

Gastrointestinal

  • Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer

    British Society of Gastroenterology (Nov 2011)

    The number of patients with chronic gastrointestinal (GI) symptoms after cancer therapies which have a moderate or severe impact on quality of life is similar to the number diagnosed with inflammatory bowel disease annually. However, in contrast to patients with inflammatory bowel disease, most of these patients are not referred for gastroenterological assessment. Clinicians who do see these patients are often unaware of the benefits of targeted investigation (which differ from those required to exclude recurrent cancer), the range of available treatments and how the pathological processes underlying side effects of cancer treatment differ from those in benign GI disorders. This paper aims to help clinicians become aware of the problem and suggests ways in which the panoply of syndromes can be managed.

Gastrointestinal Cancer

  • Guidelines for the management of oesophageal and gastric cancer

    British Society of Gastroenterology (Nov 2011)

    The original guidelines described the management of oesophageal and gastric cancer within existing practice. This paper updates the guidance to include new evidence and to embed it within the framework of the current UK National Health Service (NHS) Cancer Plan. The revised guidelines are informed by reviews of the literature and collation of evidence by expert contributors. The key recommendations are listed. The sections of the guidelines are broadly the same layout as the earlier version, with some evidence provided in detail to describe areas of development and to support the changes to the recommendations.

Gastrointestinal Disorders

Genital Infection

Glaucoma

Gout

Head and Neck Cancer

  • Diagnosis and management of head and neck cancer

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    The guideline follows the patient’s journey of care from prevention and awareness through treatment to follow up and rehabilitation, making generic recommendations which hold for all head and neck cancers. The treatment sections focus specifically on cancers of the larynx, oral cavity, oropharynx and hypopharynx, as these are the tumour sites with the highest incidences. The guideline does not cover tumours of the nasopharynx, sinuses, salivary glands or thyroid.

Head Injury

  • Early management of patients with a head injury

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    One aim of the guideline is to determine which patients are at risk of intracranial complications. Another is how to identify which patients are likely to benefit from transfer to neurosurgical care, and who should be followed up after discharge.

  • Head injury

    NICE (Nov 2011)

    This guideline was first published in June 2003. The present guideline is a partial update of only some areas where new evidence has been published since the publication of the original guideline (see CG4 website http://guidance.nice.org.uk/cg41/niceguidance/word/English).

Headache

Heart Failure

Hepatitis

Hepatitis B

Hepatitis C

  • Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C

    NICE (Sep 2012)

    This guidance should be read in conjunction with the following NICE guidance: • NICE technology appraisal guidance 75 (TA75) ‘Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C’ (which covers moderate to severe hepatitis C) • NICE technology appraisal guidance 106 (TA106) ‘Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C’.

Hip Fracture

  • Management of hip fracture in older people

    SIGN (Jun 2006)

    The aim of this guideline is to ensure that older people with a hip fracture receive optimal management. The guideline covers pre-hospital care, management in the emergency department, pre- and post-operative care, discharge planning and rehabilitation.

HIV

HIV/AIDS

Hospital Related Illness

Human Growth Hormone Deficiency

Hypertension

  • Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004_BHS IV

    British Hypertension Society Guidelines (Feb 2004)

    These guidelines update previous reports by working parties of the British Hypertension Society (BHS) in 1989, 1993 and 1999. Updating these guidelines is appropriate because, since 1999, there has been much new evidence in key areas that has allowed us to reinforce and extend previous recommendations.

  • Hypertension in pregnancy. The management of hypertensive disorders during pregnancy

    NICE (Nov 2011)

    This clinical guideline offers evidence-based advice on the care and treatment of women who have or are at risk of developing hypertension (high blood pressure) in pregnancy. It contains advice on the diagnosis and management of hypertension during pregnancy, birth and the postnatal period. It also includes advice for women with chronic hypertension who wish to conceive and for women who have had a pregnancy complicated by hypertension.

  • Hypertension: management of hypertension in adults in primary care

    NICE (Nov 2011)

    This clinical guideline (published August 2011) updates and replaces NICE clinical guideline 34 (published June 2006). It offers evidence-based advice on the care and treatment of adults with primary hypertension. New and updated recommendations on diagnosis, antihypertensive drug treatment and treatment monitoring were included in 2011.

  • Management of open angle glaucoma and ocular hypertension

    The Royal College of Ophalmologists (Jul 2004)

    This guideline covers adults (18 and older) with a diagnosis of chronic open angle glaucoma or ocular hypertension and those with chronic open angle glaucoma or ocular hypertension associated with pseudoexfoliation or pigment dispersion. In addition, the guideline will cover populations who have a higher prevalence of glaucoma and may have worse clinical outcomes including people with a family history of glaucoma, younger people (<50 years) and people who are of black African or black Caribbean descent. Options for pharmacological, surgical, laser and complimentary or alternative treatments are considered in terms of clinical effectiveness and cost effectiveness.

  • The management of hypertensive disorders during pregnancy

    NICE (Aug 2012)

    This clinical guideline contains recommendations for the diagnosis and management of hypertensive disorders during pregnancy in the antenatal, intrapartum and postnatal periods. It includes recommendations for women with chronic hypertension who wish to conceive and recommendations for advice to women after a pregnancy complicated by hypertension.

Hypogonadism

Incontinence

  • Faecal incontinence

    NICE (Jun 2004)

    The task of producing a guideline on the management of faecal incontinence in adults has presented challenges, the greatest of which has been the almost complete absence of high quality evidence for most assessment and treatment methods. The guideline development group was therefore faced with a choice: recommending nothing in the absence of good evidence, or doing the best that we could on lesser quality evidence and expert opinion. We chose the latter as we felt that the needs of patients demanded that we at least provide a starting point. But we urge the reader to remember that little of what is contained in this guideline is based on incontrovertible evidence.

  • Urinary Incontinence

    European Association of Urology (Mar 2009)

    This document presents a synthesis of the findings of the 4th International consultation on Incontinence held in July 2008. references have been included in the text, with a focus on new publications covering the time span 2005 to the present.

Infection

  • Infection control

    NICE (Jun 2003)

    The NICE clinical guideline on infection control provides a set of measures to avoid infection that should be followed by anyone giving or receiving care at home, at a health centre or clinic, or elsewhere in the community.

  • Surgical site infection

    NICE (Oct 2008)

    The advice in the NICE guideline covers adults and children who are going to have a cut through the skin for an operation.

Infective Endocarditis

Inflammatory Bowel Disease

Influenza

Irritable Bowel Syndrome (IBS)

Jaundice

  • Recognition and treatment of neonatal jaundice

    NICE (May 2010)

    This guideline provides guidance regarding the recognition, assessment and treatment of neonatal jaundice. The advice is based on evidence where this is available and on consensus-based practice where it is not.

Juvenile Idiopathic Arthritis

Liver Transplantation

Lower Urinary Tract Dysfunction

  • Neurogenic Lower Urinary Tract Dysfuction

    European Association of Urology (Mar 2007)

    The purpose of these clinical guidelines is to provide useful information for clinical practitioners on the incidence, definitions, diagnosis, therapy, and follow-up observation of the condition of neurogenic lower urinary tract dysfunction (NLUTD). These guidelines reflect the current opinion of the experts in this specific pathology and thus represent a state-of-the-art reference for all clinicians, as of the date of its presentation to the European Association of Urology (EAU).

Lung Cancer

Lymphoma

Lysosomal's disorders

Malaria

  • UK malaria treatment guidelines

    British Infection Society (Dec 2006)

    Management of malaria depends on awareness of the diagnosis and on performing the correct diagnostic tests: the diagnosis cannot be excluded until 3 blood specimens have been examined by an experienced microscopist. There are no typical clinical features of malaria, even fever is not invariably present. The optimum diagnostic procedure is examination of thick and thin blood films by an expert to detect and speciate the malarial parasites; P. falciparum malaria can be diagnosed almost as accurately using rapid diagnostic tests (RDTs) which detect plasmodial antigens or enzymes, although RDTs for other Plasmodium species are not as reliable.

Male Infertility

  • Infertility

    European Association of Urology (Apr 2010)

    The European Association of Urology (EAU) Guideline Panel on Male Infertility has prepared these guidelines aiming to assist urologists and healthcare professionals from related specialities in the treatment of male infertility.

Male Sexual Dysfunction

  • Guidelines on Male Sexual Dysfunction

    European Association of Urology (Mar 2009)

    Erectile dysfunction (ED, impotence) and premature ejaculation (PE) are the two main complaints in male sexual medicine. New oral therapies have completely changed the diagnostic and therapeutic approach to ED and the Guidelines Office of The European Association of Urology (EAU) has appointed an Expert Panel to update previously published EAU guidelines for ED or impotence. The update is based on a review of available scientific information, current research, and clinical practice in the field. The Expert Panel has also identified critical problems and knowledge gaps, setting priorities for future clinical research.

Medicines Adherence

  • Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence

    NICE (Jan 2009)

    This guideline makes recommendations about how healthcare professionals can help patients to make informed decisions by facilitating the involvement of patients in the decision to prescribe, and how they can support patients to adhere to the prescribed medicine. We have not made separate recommendations for carers and families. The principal relationship is between patient and healthcare professional, and the patient has a right to decide who should be involved in their care. With the patient's consent, carers should have access to appropriate levels of information and support.

Meningitis and Meningococcal Septicaemia

Mental Health

Multiple Sclerosis

  • Multiple sclerosis

    NICE (Feb 2004)

    The guideline has been developed by National Collaborating Centre for Chronic Conditions (NCC-CC) with a commission from the National Institute for Clinical Excellence (NICE). The commission stipulated that the guideline should concentrate on the health (ie NHS) aspects of multiple sclerosis, and that while it would include the interface with other agencies including social services, it would not discuss their detailed provision. An additional stipulation was that topics already covered by an existing NICE appraisal report would be incorporated without further assessment.

  • Use of anti - interferon beta antibody measurements in multiple sclerosis

    European Federation of Neurological Societies (Nov 2011)

    The objectives of our task force were to: (i) evaluate differences in immunogenicity of IFN β products; (ii) evaluate the reliability and give recommendations on BABs and NABs assays; (iii) evaluate the impact of NABs on clinical effi cacy and give recommendations on the clinical use of measurement of IFN β antibodies; and (iv) review the evidence on prevention of NAB development and the management of patients with NABs.

  • Use of imaging in m ultiple sclerosis

    European Federation of Neurological Societies (Nov 2011)

    Conventional magnetic resonance imaging (cMRI) has proven to be sensitive for detecting multiple sclerosis (MS) lesions and their changes over time. This exquisite sensitivity has made cMRI the most important paraclinical tool in supporting a diagnosis of MS and establishing a prognosis at the clinical onset of the disease.

Myocardial Infarction

Narcolepsy

Nervous System Disorders

Neurological Disorders

  • Cognitive rehabilitation

    European Federation of Neurological Societies (Nov 2011)

    The aim was to evaluate the existing evidence for the clinical effectiveness of cognitive rehabilitation in stroke and TBI, and provide recommendations for neurological practice. The results were published in 2003 in the European Journal of Neurology and updated in 2005. The present chapter is an update and a revision of these guidelines.

  • Neurological problems in liver transplantation

    European Federation of Neurological Societies (Nov 2011)

    The recommendation section includes statements classifi ed in levels A – C derived from Classes I – III of evidence according to EFNS guidelines when feasible. For those clinical areas exhibiting Class IV scientifi c evidence, recommendations were based on the agreement obtained and indicated in the text as Good Practice Points (GPP).

Neuropathic Pain

  • EFNS guidelines on neuropathic pain assessment

    European Federation of Neurological Societies (Nov 2011)

    We have revised the previous EFNS guidelines on neuropathic pain (NP) assessment, which aimed to provide recommendations for the diagnostic process, screening tools and questionnaires, quantitative sensory testing (QST), microneurography, pain-related reflexes and evoked potentials, functional neuroimaging and skin biopsy.

  • Neuropathic pain - pharmacological management

    NICE (Mar 2010)

    The full guideline on the pharmacological management of neuropathic pain in adults in non-specialist settings. It contains all the recommendations for healthcare professionals and NHS bodies, details of how they were developed and reviews of the evidence.

Nocturnal Enuresis

Non-Neurogenic Male LUTS

  • Guidelines on Conservative Treatment of Non-neurogenic Male LUTS

    European Association of Urology (Apr 2010)

    The new guidelines panel consists of urologists, a pharmacologist, an epidemiologist, and a statistician and has been working on the topic for the last 3 years without financial interests. The new Guidelines are intended to give advice on the pathophysiology and definitions, assessment, treatment, and follow-up of the various forms of non-neurogenic LUTS in men aged 40 years or older. These guidelines cover mainly BPH-LUTS, OAB, and nocturnal polyuria. Lower urinary tract symptoms in children or women and LUTS due to other causes (e.g. neurological diseases, urological tumours of the lower urinary tract, stones disease, or urinary incontinence) are covered by separate EAU guidelines. The new guidelines are primarily written for urologists but can be used by general practitioners as well.

Nutrition Support

Nutrition/Food Allergy

Obesity

  • Management of Obesity

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    This guideline provides evidence based recommendations on the prevention and treatment of obesity within the clinical setting, in children, young people and adults. The focus of prevention is on primary prevention, defined here as intervention when individuals are at a healthy weight and/or overweight to prevent or delay the onset of obesity.

  • Obesity

    NICE (Dec 2006)

    This is the first national guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children in England and Wales.

Obsessive-Compulsive Disorder

  • Obsessive-compulsive disorder

    NICE (Jan 2006)

    This guideline has been developed to advise on the identification, treatment and management of obsessive-compulsive disorder (OCD) and body dysmorphic disorder (BDD).

Osteoarthritis

Osteoporosis

Ovarian Cancer

Paediatric Urology

  • Guidelines on Paediatric Urology

    European Association of Urology (Nov 2011)

    guidelines. The aim of this close collaboration between a subspecialty group and its parent specialty is to make a document available that may help to increase the quality of care for children with urological problems. The majority of urological clinical problems in children are distinct and in many ways different to those in adults. The aim of this work is to outline a practical and preliminary approach to paediatric urological problems. Complex and rare conditions that require special care with experienced doctors should be referred to designated centres where paediatric urology practice has been fully established and a multidisciplinary approach is available.

Pain Management

  • Control of pain in adults with cancer

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    This guideline provides recommendations based on current evidence for best practice in the management of pain in adult patients who have cancer. The guideline includes advice mainly concerning pain secondary to the cancer, but many of the principles outlined are applicable to coexisting painful conditions and pain secondary to treatment of the cancer. It excludes the treatment of pain in children under the age of 12.

Parkinson's Disease

  • Parkinson's disease

    NICE (May 2008)

    The NICE clinical guideline on Parkinson's disease covers: - the diagnosis of Parkinson's disease and checking the diagnosis regularly - the way people with Parkinson's disease should receive information - the medicines that can be used - other ways of helping with symptoms - how to care for people whose mental health is affected - the care people with Parkinson's disease should receive at the end of their life

Parkinson’s Disease

Perioperative Hypothermia

  • Perioperative hypothermia (inadvertent)

    NICE (Apr 2008)

    This guidance covers the care and treatment of people who are having an operation in hospital, in the NHS in England and Wales, to reduce their risk of getting cold before, during or after their operation.

Peripheral Arterial Diseases

Physical Activity

Pleural Disease

Pneumonia

Polio

  • Post-polio syndrome

    European Federation of Neurological Societies (Nov 2011)

    The aim was to revise the existing EFNS task force document, with regard to a common defi nition of PPS, and evaluation of the existing evidence for the effectiveness and safety of therapeutic interventions. By this revision, clinical guidelines for management of PPS are provided.

Post-Traumatic Stress Disorder (PTSD)

  • Post-traumatic stress disorder (PTSD)

    NICE (Mar 2005)

    The NICE clinical guideline on post-traumatic stress disorder (PTSD) covers: - the care people with PTSD can expect to receive from their GP or other healthcare professional - the information they can expect to receive about their condition and its treatment - what treatment they can expect, which may include psychological therapies and drug treatment - the services that may help them with PTSD, including specialist mental health services

Postnatal Health

Pregnancy

  • A model for service provision for pregnant women with complex social factors

    NICE (Sep 2012)

    The guideline has been developed in collaboration with the Social Care Institute for Excellence. It is for professional groups who are routinely involved in the care of pregnant women, including midwives, GPs and primary care professionals who may encounter pregnant women with complex social factors in the course of their professional duties. It is also for those who are responsible for commissioning and planning healthcare and social services. In addition, the guideline will be of relevance to professionals working in social services and education/childcare settings, for example school nurses, substance misuse service workers, reception centre workers and domestic abuse support workers.

  • ESC Guidelines on the management of cardiovascular diseases during pregnancy

    European Society of Cardiology (Nov 2011)

    Knowledge of the risks associated with CVD during pregnancy and their management are of pivotal importance for advising patients before pregnancy. Therefore, guidelines on disease management in pregnancy are of great relevance. Such guidelines have to give special consideration to the fact that all measures concern not only the mother, but the fetus as well.

Preoperative Tests

  • Preoperative tests

    NICE (Aug 2003)

    The NICE clinical guideline on preoperative tests covers tests that are often carried out when someone is due to have a planned (elective) surgical operation and that are carried out before the operation by doctors or nurses in hospitals, preoperative assessment clinics or, in some cases, in the GP’s surgery or health centres. The NICE guideline makes recommendations on the circumstances in which the tests should be done, not done, or considered – for example, whether a certain test is recommended may depend on the patient’s age or how serious the planned operation is.

Pressure Relieving Devices

  • Pressure relieving devices

    NICE (Dec 2003)

    The NICE clinical guideline on pressure relieving devices makes recommendations about how the risk of developing a pressure ulcer can be assessed and how pressure ulcers can be prevented by using devices designed to reduce pressure.

Pressure Ulcer Management

  • Pressure ulcer management

    NICE (Sep 2005)

    This guideline makes evidence-based recommendations on the management of pressure ulcers in primary and secondary care.

Primary Dystonias

Prostate Cancer

  • Prostate cancer

    NICE (Feb 2008)

    This is the first clinical guideline, rather than cancer service guidance, produced by the National Collaborating Centre for Cancer (NCC-C) and deals with a very common cancer. Its management often presents men and their health professionals with difficult decisions about the most appropriate treatment and we hope that this document will provide helpful and appropriate guidance. There are many areas where the research evidence is inadequate or incomplete and so some recommendations are based on the judgements and consensus of the guideline development group (GDG) using the best available evidence. We hope that the recommendations for further research will be taken up urgently by national research bodies and provide more robust evidence for the future.

  • Prostate Cancer

    European Association of Urology (Apr 2010)

    The European Association of Urology (EAU) Guidelines Group for Prostate Cancer have prepared this guidelines document to assist medical professionals assess the evidence-based management of prostate cancer. The multidisciplinary panel of experts include urologists, radiation oncologists, a medical oncologist, and a pathologist.

Psoriasis

  • Adalimumab for the treatment of psoriasis

    NICE (Jun 2008)

    Adalimumab is recommended as a possible treatment for adults with plaque psoriasis only if: their condition is severe and their condition has not improved with other treatments such as ciclosporin, methotrexate and PUVA (psoralen and long-wave ultraviolet radiation), or they have had side effects with these in the past or there is a medical reason why they should not be given these treatments. Adalimumab treatment should be continued beyond 16 weeks only if the psoriasis has clearly improved within this time. The severity of a person's psoriasis before and during treatment should be assessed by considering the redness, thickness and scaliness of the plaques, the area of the body involved, and how the condition affects the person's quality of life. When assessing a person's psoriasis, healthcare professionals should take into account any disabilities or difficulties in communicating, which might mean that standard assessments do not provide accurate information about their condition.

Psoriasis and Psoriatic Arthritis

  • Diagnosis and management of psoriasis and psoriatic arthritis in adults

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    This guideline provides recommendations based on current evidence for best practice in the diagnosis and management of psoriasis and PsA in adults. It covers early diagnosis of PsA, screening for comorbidities, assessment of disease severity, non-pharmacological treatment, psychological interventions, occupational health, topical treatment, phototherapy, systemic therapy, biologic treatment, referral pathways and the provision of patient information. It excludes psoriasis and PsA in children. Pregnancy and pre-conception care (eg for patients on systemic therapies) are not addressed. Other inflammatory conditions sometimes associated with psoriasis such as palmoplantar pustulosis are not addressed.

Pulmonary Hypertension

Recurrent Sore Throat

Respiratory Diseases

Rheumatoid Arthritis

Rhinitis

Risk Assessments

Schizophrenia

Self-Harm

  • Self-harm

    NICE (Nov 2004)

    The NICE clinical guideline on self-harm covers: - the care people who harm themselves can expect to receive from healthcare professionals in hospital and out of hospital - the information they can expect to receive - what they can expect from treatment - what kinds of services best help people who harm themselves

Sexual Development Disorders

Smoking

  • School-based interventions to prevent the uptake of smoking among children

    NICE (Feb 2012)

    This guidance is for all those responsible for preventing the uptake of smoking by children and young people aged under 19. This includes those working in the NHS, local authorities, education and the wider public, private, voluntary and community sectors. It may also be of interest to children and young people, their parents or carers and other members of the public. For the purposes of this guidance, ‘schools’ includes ‘extended schools’ (where childcare or informal education is provided outside school hours), pupil referral units, secure training and local authority secure units. It also includes further education colleges.

Soft Tissue Sarcoma

  • Trabectedin for the treatment of advanced soft tissue sarcoma

    NICE (Feb 2012)

    Trabectedin is recommended as a possible treatment for people with advanced soft tissue sarcoma if: treatment with anthracyclines and ifosfamide has failed, or they cannot tolerate anthracyclines and ifosfamide, or anthracyclines and ifosfamide are unsuitable. The manufacturer of trabectedin has agreed to a 'patient access scheme', which means that when a person needs more than five trabectedin treatments, it provides the sixth and any further trabectedin treatments to the NHS free of charge.

Stroke

Swine Flu

Syncope

Testicular Cancer

  • Management of adult testicular germ cell tumours

    Scottish Intercollegiate Guidelines Network (Nov 2011)

    This guideline provides recommendations based on current evidence for best practice in the management of testicular cancer. It excludes the management of germ cell testicular tumours in children, germ cell tumours in women and extragonadal tumours.

  • Testicular Cancer

    European Association of Urology (Mar 2009)

    A multidisciplinary team of urologists, medical oncologists, radiotherapists and a pathologist were involved in producing this text, which is based on a structured review of the literature from January 2008 until December 2010 for both the germ cell tumour and non-germ cell sections. Also, data from meta-analysis studies, Cochrane evidence, and the recommendations of the European Germ Cell Cancer Collaborative Group Meeting in Amsterdam in November 2006 have been included.

Thrombosis

Thyroid Function Tests

Transplantation

Tuberculosis

Urinary Cancer

Urinary Tract Infection

Urolithiasis

  • Guidelines on Urolithiasis

    European Association of Urology (Nov 2011)

    The European Association of Urology (EAU) Urolithiasis Guideline Panel have prepared these guidelines to help urologists assess the evidence-based management of stones/calculi and to incorporate guideline recommendations into their clinical practice.

Urological Infections

  • Guidelines on Urological Infections

    European Association of Urology (Nov 2011)

    Due to the increasing threat of resistant pathogens worldwide, it has become imperative to limit the use of antibiotics, and consequently, to monitor established treatment strategies closely. It is the ambition of the present guidelines to provide both the urologist and the physician from other medical specialties with advices in their daily practice. The guidelines cover male and female UTIs, male genital infections, and special fields such as UTIs in paediatric urology, immunosuppression, renal insufficiency and kidney transplant recipients. Much attention is given to antibiotic prophylaxis, with the aim of reducing the misuse of antibiotics in conjunction with surgery. High quality clinical research is strongly encouraged.

Urology

  • Guidelines on Lasers and Technologies

    European Association of Urology (Mar 2012)

    The European Association of Urology (EAU) Guidelines Office have set up a Guidelines Working Panel to analyse the scientific evidence published in the world literature on lasers in urological practice. The working panel consists of experts who, through these guidelines, present the findings of their analysis, together with recommendations for the application of laser techniques in urology. The guidelines also include information on the characteristics of lasers, which the panel believes will be very helpful to clinicians.

Venous Thromboembolism

Violent Behaviour

  • Violence

    NICE (Feb 2005)

    The NICE clinical guideline on managing disturbed/violent behaviour covers how people in the NHS should try to prevent violent situations from happening, and what they should do if someone becomes violent.

Women's Health

  • Heavy menstrual bleeding

    NICE (Jan 2011)

    Heavy menstrual bleeding (HMB) is defined as excessive menstrual blood loss which interferes with a woman's physical, social, emotional and/or material quality of life. It can occur alone or in combination with other symptoms.

  • Long-acting reversible contraception

    NICE (Oct 2005)

    The NICE clinical guideline on long-acting reversible contraception (LARC) offers the best-practice advice for all women of reproductive age who may wish to regulate their fertility by using LARC methods. It covers specific issues for the use of these methods during the menarche and before the menopause, and by particular groups, including women who have HIV, learning disabilities or physical disabilities, or are younger than 16 years.

Atopic Dermatitis- understanding, management, diagnosis and treatment information Lysosomal storage disorders (LSDs) are a group of progressive and often fatal genetic diseases that are caused by an inborn error of metabolism Gastrointestinal stromal tumours (GISTs) are the most common mesenchymal tumours of the gastrointestinal (GI) tract. Pharmacologic management of asthma aims to control symptoms, prevent exacerbations and provide the best possible pulmonary function with minimal medications, side effects and risk factors.

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES